Loading
A phase 1/2 trial of IBI343, capecitabine and cAPOX (capecitabine, oxaliplatin) in pancreatic cancer, run by Zhejiang Cancer Hospital, now recruiting.
IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer is a phase 1/2, interventional study registered as NCT07692750 by Zhejiang Cancer Hospital, with a registry enrolment figure of 56 participants, started 2025-04-30 and due to reach its primary completion in 2027-06-30. Interventions recorded: IBI343+ capecitabine; IBI343+Capecitabine+oxaliplatin. Conditions listed: Advanced Pancreatic Cancer. Primary outcome: Objective Response Rate (ORR) according to RECIST v1.1; Adverse Event, Treatment-Emergent Adverse Event, Adverse Event of Special Interest, Serious Serious Adverse EventChanges in laboratory tests, physical examinations, vital signs, etc., incidence, and correlation with experimental drugs. Sites: China. No results are recorded here; the registry entry is the source.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares IBI343, Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, Antibody-drug conjugate (ADC) and the tag pancreatic-deep-dive.
Shares CAPOX (capecitabine, oxaliplatin), Pancreatic cancer trials open today (registry snapshot and UK sites), Capecitabine, Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares IBI343, Pancreatic cancer trials open today (registry snapshot and UK sites), Antibody-drug conjugate (ADC) and the tag pancreatic-deep-dive.
Shares CAPOX (capecitabine, oxaliplatin), Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, Cytotoxic chemotherapy and the tag pancreatic-deep-dive.
Shares CAPOX (capecitabine, oxaliplatin), Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, Cytotoxic chemotherapy and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Capecitabine, Metastatic pancreatic ductal adenocarcinoma, Cytotoxic chemotherapy and the tag pancreatic-deep-dive.
Shares CAPOX (capecitabine, oxaliplatin), Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, Cytotoxic chemotherapy and the tag pancreatic-deep-dive.
Shares CAPOX (capecitabine, oxaliplatin), Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma, Cytotoxic chemotherapy and the tag pancreatic-deep-dive.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/